Today's Rundown Pivoting from clinical to commercial, MorphoSys loses chief scientist AbbVie doubles down on Harpoon with $50M option on BCMA drug Immunitas snags $39M to bring new I-O approach to the clinic ABPI calls for increased investment in U.K. clinical research FDA Commissioner nominee Hahn promises to put science above politics FDA urged to probe naltrexone implant tests on prison inmates Could this ring-shaped DNA change how we treat cancer? Featured Story | | | Thursday, November 21, 2019 After the loss of its longtime CEO at the start of the year, a morphing MorphoSys is now losing its chief scientific officer just as it gears up for its first commercial launch. |
|
|---|
|
Top Stories Thursday, November 21, 2019 AbbVie and Harpoon Therapeutics inked a $50 million licensing deal for the latter’s BCMA-targeting multiple myeloma candidate and added up to six new targets to a discovery deal inked in October 2017. Harpoon will collect another $50 million when it starts a phase 1/2 trial and stands to pick up $510 million in total. Thursday, November 21, 2019 Immunitas Therapeutics is launching with $39 million in series A financing to propel at least one monoclonal antibody into the clinic. Its platform uses single-cell genomic sequencing to “dissect” the tumor microenvironment and uncover new drug targets to create new targeted immune-oncology medicines. Thursday, November 21, 2019 The U.K. pharma industry has called for increased investment in clinical research in response to rising global competition for trials. Data collected by the Association of the British Pharmaceutical Industry show the U.K. is currently a leading European location for clinical trials, but that position could be threatened by Brexit and other factors. Wednesday, November 20, 2019 After former FDA commissioner Scott Gottlieb stepped down, the Trump administration is working to get a successor in place. Nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more. Thursday, November 21, 2019 The FDA is being urged to investigate California biotech BioCorRx amid claims that it tested an unapproved drug implant for dependency on prison inmates without institutional oversight or thoroughly gathered legal consent. Thursday, November 21, 2019 A team led by scientists at the University of California, San Diego and Stanford University suggests a type of doughnut-shaped DNA outside the chromosome gives cancer cells their malignant qualities, promoting the expression of cancer-driving oncogenes and helping tumors evolve and resist treatments. Enrollment Showcase Resources Sponsored by: Amazon Web Services From IoT to data management to high-performance computing and machine learning, leading life sciences organizations are using Amazon Web Services (AWS) to develop scalable, global, predictable, and secure solutions to modernize clinical trials while mitigating risks Sponsored by: Outer Edge Technology, LLC See why visionaries outsource the design and management of the infrastructure allowing their scientists to innovate. Sponsored by: Veeva Systems Medical Affairs 2025 brings together leading perspectives from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly, and other innovative life sciences organizations on key challenges impacting medical affairs and a roadmap for success in the coming decade. Sponsored by: SHYFT Analytics This whitepaper provides a snapshot of where the biopharma industry is now, where it's heading, and how companies are allocating their resources to adapt & grow. Sponsored by: IBM Watson Health IBM’s highlighted solutions reside in a security-rich cloud environment—home for capturing, managing and analyzing clinical study data with control, accuracy and confidence. These solutions lay the groundwork for further integration with IBM® Watson® cognitive technology. Sponsored by: IBM Watson Health Inpatient View and Outpatient View are powered by robust data assets and use sophisticated projection methodologies to help ensure accuracy of reporting. Sponsored by: IBM Watson Health Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, we believe, is essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars. Learn more. Sponsored by: ON24 Discover solutions to the most common challenges faced by medical device companies. Sponsored by: Eli Lilly and Company in partnership with Xcenda Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system. Sponsored by: Clarivate Analytics 18 high-value new licensing deals worth in excess of $500 million took place during the second quarter of 2019 -Get the Q2 2019 Biopharma licensing report for full details and insights. Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BBK Worldwide Get the latest data on how people are using apps to manage their health, and learn how you can leverage it in the development of your next clinical trial app. Sponsored by: Blue Latitude Health Report: How to design digital services that deliver value and improve outcomes for patients, healthcare professionals and the healthcare systems they serve Sponsored by: Article Galaxy powered by Reprints Desk This white paper examines the skyrocketing cost of drug development and provides step-by-step guidance for executing a successful fail fast strategy. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Countdown to Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register Now at www.drugstomarket.com/drugbootcamp and start Pre-Boot Camp Preparation FierceBiotech Executive Breakfast at the J.P. Morgan Healthcare Conference 2020 January 14, 2020 | The Fairmont Hotel | San Francisco, CA 4th Annual Gene Therapy for Rare Disorders March 30 – April 2, 2020 | Boston, MA A Rare Affair for Rare Diseases January 12, 2020 | San Francisco, CA | 